PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS

被引：310
作者：
HUMPHREY, MJ [1 ]
JEVONS, S [1 ]
TARBIT, MH [1 ]
机构：
[1] PFIZER LTD,CENT RES,SANDWICH,KENT,ENGLAND
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1985年 / 28卷 / 05期
关键词：
D O I：
10.1128/AAC.28.5.648
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：648 / 653
页数：6
相关论文
共 18 条
[1]   KETOCONAZOLE, AN ORAL ANTIFUNGAL - LABORATORY AND CLINICAL-ASSESSMENT OF IMIDAZOLE DRUGS [J].
BORELLI, D ;
FUENTES, J ;
LEIDERMAN, E ;
RESTREPO, A ;
BRAN, JL ;
LEGENDRE, R ;
LEVINE, HB ;
STEVENS, DA .
POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (647) :657-661
[2]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[3]   SYSTEMIC ANTIFUNGAL POTENTIAL, SAFETY, BIOTRANSPORT AND TRANSFORMATION OF MICONAZOLE NITRATE [J].
BRUGMANS, J ;
VANCUTSE.J ;
HEYKANTS, J ;
SCHUERMANS, V ;
THIENPONT, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (02) :93-99
[4]   CLINICAL PHARMACOKINETICS OF SYSTEMIC ANTI-FUNGAL DRUGS [J].
DANESHMEND, TK ;
WARNOCK, DW .
CLINICAL PHARMACOKINETICS, 1983, 8 (01) :17-42
[5]   PHARMACOKINETICS OF KETOCONAZOLE IN NORMAL SUBJECTS [J].
DANESHMEND, TK ;
WARNOCK, DW ;
TURNER, A ;
ROBERTS, CJC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 (04) :299-304
[6]   TREATMENT OF FUNGAL MENINGITIS WITH MICONAZOLE [J].
DERESINSKI, SC ;
LILLY, RB ;
LEVINE, HB ;
GALGIANI, JN ;
STEVENS, DA .
ARCHIVES OF INTERNAL MEDICINE, 1977, 137 (09) :1180-1185
[7]  
DUHM B, 1974, POSTGRAD MED J, V50, P13
[8]   THERAPEUTIC FAILURES WITH MICONAZOLE [J].
FISHER, JF ;
DUMA, RJ ;
MARKOWITZ, SM ;
SHADOMY, S ;
ESPINELINGROFF, A ;
CHEW, WH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (06) :965-968
[9]  
Gascoigne E.R., 1981, CLIN RES REV, V1, P177
[10]  
GIBALDI M, 1982, PHARMACOKINETICS
12